Prostate, 0270-4137

Journal

More filtering options
  1. 2019
  2. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

    Wu, X., Scott, H., Carlsson, S. V., Sjoberg, D. D., Cerundolo, L., Lilja, H., Prevo, R., Rieunier, G., Macaulay, V., Higgins, G. S., Verrill, C. L., Lamb, A. D., Cunliffe, V. T., Bountra, C., Hamdy, F. C. & Bryant, R. J., 2019 Jul 1, In : Prostate. 79, 10, p. 1079-1089 11 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Role of serum response factor expression in prostate cancer biochemical recurrence

    Prencipe, M., Fabre, A., Murphy, T. B., Vargyas, E., O'Neill, A., Anders Bjartell, Tasken, K. A., Grytli, H. H., Svindland, A., Berge, V., Eri, L. M., Gallagher, W. & Watson, R. W., 2018 Jul, In : The Prostate. 78, 10, p. 724-730 7 p.

    Research output: Contribution to journalArticle

  5. 2017
  6. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer

    Josefsson, A., Linder, A., Flondell Site, D., Canesin, G., Stiehm, A., Aseem Anand, Anders Bjartell, Damber, J-E. & Welén, K., 2017 Jun 1, In : Prostate. 77, 8, p. 849-858 10 p.

    Research output: Contribution to journalArticle

  7. Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer

    Alva, A., Nordquist, L., Daignault, S., George, S., Ramos, J., Albany, C., Isharwal, S., McDonald, M., Campbell, G., Danchaivijitr, P., Yentz, S., Aseem Anand & Yu, E. Y., 2017 Apr 1, In : Prostate. 77, 5, p. 479-488 10 p.

    Research output: Contribution to journalArticle

  8. 2015
  9. Relationship Between Serum Response Factor and Androgen Receptor in Prostate Cancer

    Prencipe, M., O'Neill, A., O'Hurley, G., Nguyen, L. K., Fabre, A., Anders Bjartell, Gallagher, W. M., Morrissey, C., Kay, E. W. & Watson, R. W., 2015, In : The Prostate. 75, 15, p. 1704-1717

    Research output: Contribution to journalArticle

  10. 2014
  11. 2012
  12. Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)

    Jennbacken, K., Welen, K., Olsson, A., Axelsson, B., Torngren, M., Damber, J-E. & Tomas Leanderson, 2012, In : The Prostate. 72, 8, p. 913-924

    Research output: Contribution to journalArticle

  13. Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat

    Aumueller, G., Doll, A., Wennemuth, G., Dizeyi, N., Abrahamsson, P-A. & Wilhelm, B., 2012, In : The Prostate. 72, 3, p. 326-337

    Research output: Contribution to journalArticle

  14. 2010
  15. Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.

    Eva Källberg, Wikström, P., Bergh, A., Fredrik Ivars & Tomas Leanderson, 2010, In : The Prostate. 70, 13, p. 1461-1470

    Research output: Contribution to journalArticle

  16. Role of the ProteinTyrosine Phosphatase SHP-I in Interleukin-6 Regulation of Prostate Cancer Cells

    Tassidis, H., Culig, Z., Gjörloff Wingren, A. & Härkönen, P., 2010, In : The Prostate. 70, 14, p. 1491-1500

    Research output: Contribution to journalArticle

  17. 2009
  18. Association of Reported Prostate Cancer Risk Alleles With PSA Levels Among Men Without a Diagnosis of Prostate Cancer

    Wiklund, F., Zheng, S. L., Sun, J., Adami, H-O., Hans Lilja, Hsu, F-C., Stattin, P., Adolfsson, J., Cramer, S. D., Duggan, D., Carpten, J. D., Chang, B-L., Isaacs, W. B., Gronberg, H. & Xu, J., 2009, In : The Prostate. 69, 4, p. 419-427

    Research output: Contribution to journalArticle

  19. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.

    Monsef, N., Soller, M., Isaksson, M., Abrahamsson, P-A. & Panagopoulos, I., 2009, In : The Prostate. 69, p. 909-916

    Research output: Contribution to journalArticle

  20. 2008
  21. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

    Rebecka Hellsten, Johansson, M. H., Dahlman, A. K., Dizeyi, N., Olov Sterner & Anders Bjartell, 2008, In : The Prostate. 68, 3, p. 269-280

    Research output: Contribution to journalArticle

  22. Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer

    Ramberg, H., Eide, T., Krobert, K. A., Levy, F. O., Dizeyi, N., Anders Bjartell, Abrahamsson, P-A. & Tasken, K. A., 2008, In : The Prostate. 68, 10, p. 1133-1142

    Research output: Contribution to journalArticle

  23. 2007
  24. Androgens and prostate cancer risk: A prospective study

    Wirén, S., Tanja Stocks, Rinaldi, S., Hallmans, G., Bergh, A., Stenman, U. H., Kaaks, R. & Stattin, P., 2007 Aug 1, In : Prostate. 67, 11, p. 1230-1237 8 p.

    Research output: Contribution to journalArticle

  25. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.

    Monsef, N., Helczynski, L., Åke Lundwall & Sven Påhlman, 2007, In : The Prostate. 67, 11, p. 1219-1229

    Research output: Contribution to journalArticle

  26. 2006
  27. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.

    Isaacs, J. T., Pili, R., Qian, D. Z., Dalrymple, S. L., Garrison, J. B., Kyprianou, N., Bjork, A., Olsson, A. & Tomas Leanderson, 2006, In : The Prostate. 66, 16, p. 1768-1778

    Research output: Contribution to journalArticle

  28. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.

    Anders Bjartell, Johansson, R., Thomas Björk, Gadaleanu, V., Åke Lundwall, Hans Lilja, Kjeldsen, L. & Udby, L., 2006, In : The Prostate. 66, Dec 30, p. 591-603

    Research output: Contribution to journalArticle

  29. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug

    Janssen, S., Rosen, D. M., Ricklis, R. M., Dionne, C. A., Hans Lilja, Christensen, S. B., Isaacs, J. T. & Denmeade, S. R., 2006, In : The Prostate. 66, 4, p. 358-368

    Research output: Contribution to journalArticle

  30. 2005
  31. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue

    Steuber, T., Niemela, P., Haese, A., Pettersson, K., Erbersdobler, A., Chun, K. H. F., Graefen, M., Kattan, M. W., Huland, H. & Hans Lilja, 2005, In : The Prostate. 63, 1, p. 13-18

    Research output: Contribution to journalArticle

  32. Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.

    Anders Bjartell, Paju, A., Zhang, W-M., Gadaleanu, V., Jens Ceder, Landberg, G. & Stenman, U-H., 2005, In : The Prostate. 64, 1, p. 29-39

    Research output: Contribution to journalArticle

  33. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue

    Lintula, S., Stenman, J., Anders Bjartell, Nordling, S. & Stenman, UH., 2005, In : The Prostate. 63, 4, p. 324-329

    Research output: Contribution to journalArticle

  34. 2004
  35. Androgen receptor CAG repeat length correlates with semen PSA levels in adolescence.

    Yvonne Giwercman, Richthoff, J., Hans Lilja, Anderberg, C., Abrahamsson, P-A. & Aleksander Giwercman, 2004, In : The Prostate. 59, 3, p. 227-233

    Research output: Contribution to journalArticle

  36. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.

    Dizeyi, N., Anders Bjartell, Nilsson, E., Hansson, J., Gadaleanu, V., Cross, N. & Abrahamsson, P-A., 2004, In : The Prostate. 59, 3, p. 328-336

    Research output: Contribution to journalArticle

  37. 2003
  38. Expression of protein C inhibitor (PCI) in benign and malignant prostatic tissues

    Cao, Y., Charlotte Becker, Åke Lundwall, Anders Christensson, Gadaleanu, V., Hans Lilja & Anders Bjartell, 2003, In : Prostate. 57, 3, p. 196-204

    Research output: Contribution to journalArticle

  39. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells InVitro or prostate cancer xenografts in vivo

    Denmeade, SR., Litvinov, I., Sokoll, LJ., Hans Lilja & Isaacs, JT., 2003, In : The Prostate. 56, 1, p. 45-53

    Research output: Contribution to journalArticle

  40. Quantitative PSA RT-PCR for preoperative staging of prostate cancer

    Kurek, R., Ylikoski, A., Renneberg, H., Konrad, L., Aumuller, G., Roddiger, SJ., Zamboglou, N., Tunn, UW. & Hans Lilja, 2003, In : The Prostate. 56, 4, p. 263-269

    Research output: Contribution to journalArticle

  41. The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer

    Haese, A., Graefen, M., Charlotte Becker, Noldus, J., Katz, J., Cagiannos, I., Kattan, M., Scardino, PT., Huland, E., Huland, H. & Hans Lilja, 2003, In : The Prostate. 54, 3, p. 181-186

    Research output: Contribution to journalArticle

  42. 2002
  43. Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancer.

    Jens Ceder, Anders Bjartell, Gadaleanu, V., Dizeyi, N. & Abrahamsson, P-A., 2002, In : The Prostate. 53, 1, p. 50-59

    Research output: Contribution to journalArticle

  44. 2001
  45. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing

    Denmeade, S. R., Lövgren, J., Khan, S. R., Hans Lilja & Isaacs, J. T., 2001, In : The Prostate. 48, 2, p. 122-126

    Research output: Contribution to journalArticle

  46. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml

    Haese, A., Graefen, M., Steuber, T., Charlotte Becker, Pettersson, K., Piironen, T., Noldus, J., Huland, H. & Hans Lilja, 2001, In : The Prostate. 49, 2, p. 101-109

    Research output: Contribution to journalArticle

  47. Neuroendocrine cells and nerves in the prostate of the guinea pig: effects of peripheral denervation and castration

    Stefan Acosta, Dizeyi, N., Stefan Pierzynowski, Per Alm & Abrahamsson, P-A., 2001, In : The Prostate. 46, 3, p. 191-199

    Research output: Contribution to journalArticle

  48. 2000
  49. Calcitonin and calcitonin gene-related peptide in the human prostate gland

    Abrahamsson, P-A., Dizeyi, N., Per Alm, di Sant'Agnese, P. A., Deftos, L. J. & Aumuller, G., 2000, In : The Prostate. 44, 3, p. 181-186

    Research output: Contribution to journalArticle

  50. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats

    Johansson, S., Landstrom, M., Leif Bjermer & Henriksson, R., 2000, In : The Prostate. 42, 4, p. 253-259

    Research output: Contribution to journalArticle